Douglas Lane & Associates’s HCA Healthcare HCA Stock Holding History

Douglas Lane & Associates’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$500K	Hold	1,283	–	–	0.01%	193
2026 Q1	$607K	Sell	1,283 -19	-1%	-$9.56K	0.01%	170
2025 Q4	$608K	Hold	1,302	–	–	0.01%	170
2025 Q3	$555K	Hold	1,302	–	–	0.01%	173
2025 Q2	$499K	Buy	1,302 +262	+25%	+$94.4K	0.01%	175
2025 Q1	$359K	Hold	1,040	–	–	0.01%	201
2024 Q4	$312K	Hold	1,040	–	–	﹤0.01%	206
2024 Q3	$423K	Hold	1,040	–	–	0.01%	193
2024 Q2	$334K	Hold	1,040	–	–	﹤0.01%	199
2024 Q1	$347K	Hold	1,040	–	–	﹤0.01%	201
2023 Q4	$282K	Hold	1,040	–	–	﹤0.01%	210
2023 Q3	$256K	Hold	1,040	–	–	﹤0.01%	211
2023 Q2	$316K	Hold	1,040	–	–	0.01%	195
2023 Q1	$274K	Hold	1,040	–	–	﹤0.01%	205
2022 Q4	$250K	Buy	+1,040	New	+$233K	﹤0.01%	212
2022 Q2	–	Sell	-1,040	Closed	-$261K	–	219
2022 Q1	$261K	Hold	1,040	–	–	﹤0.01%	207
2021 Q4	$267K	Hold	1,040	–	–	﹤0.01%	211
2021 Q3	$252K	Hold	1,040	–	–	﹤0.01%	206
2021 Q2	$215K	Buy	+1,040	New	+$212K	﹤0.01%	217
2020 Q1	–	Sell	-1,380	Closed	-$204K	–	202
2019 Q4	$204K	Buy	+1,380	New	+$185K	﹤0.01%	202

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Douglas Lane & Associates's HCA Position: Q2 2026 in Review

Douglas Lane & Associates held its HCA Healthcare (HCA) position steady in Q2 2026 at 1,283 shares worth $500K. The position accounts for 0.01% of the portfolio, ranked #193.

Douglas Lane & Associates first reported a position in HCA in Q4 2019 and has held it in 20 quarters since. The position peaked at $608K in Q4 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Douglas Lane & Associates held 1,283 shares of HCA Healthcare worth $500K as of Q2 2026.
Douglas Lane & Associates left its HCA Healthcare share count unchanged in Q2 2026.
HCA Healthcare made up 0.01% of Douglas Lane & Associates's portfolio in Q2 2026, its #193 holding.
Douglas Lane & Associates first reported a position in HCA Healthcare in Q4 2019 and has held it in 20 quarters since.
Douglas Lane & Associates's HCA Healthcare position peaked at $608K in Q4 2025.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.